A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.
Also called NCT02954692
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 112 participants
- Sponsor
- Registry
-
NCT02954692
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Türkiye
- Registry status
- Completed
Technical summary
Registry record NCT02954692. Allocation not applicable; no masking; primary purpose treatment. Start 2016-11-30 (registry gives no type); primary completion 2017-12-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
- Acronym
- EASE
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- INSULIN GLARGINE (U300)
- Intervention (Drug)
- metformin
- Intervention (Drug)
- sulfonylurea
- Intervention (Drug)
- meglitinides
- Intervention (Drug)
- thiazolidinediones
- Intervention (Drug)
- alpha-glucosidase inhibitors
- Intervention (Drug)
- GLP1 Receptor Agonist
- Intervention (Drug)
- Dipeptidyl peptidase-IV (DPP-IV) inhibitors
- Intervention (Drug)
- Sodium-glucose transport-2 (SGLT-2) inhibitors
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct02954692- Content hash
57d0f73f581d77814046498c65c5504f77081739c3b1c6d06d1ffe8fca2f6145